The new techniques help women with faulty mitochondria, the energy source in a cell, from passing on to their babies defects that can result in such diseases as muscular dystrophy, epilepsy, heart problems and mental retardation.
About one in 200 children is born every year in Britain with a mitochondrial disorder.
For a woman with faulty mitochondria, scientists take only the healthy genetic material from her egg or embryo. They then transfer that into a donor egg or embryo that still has its healthy mitochondria but has had the rest of its key DNA removed. The fertilised embryo is then transferred into the womb of the mother.
British tabloids jumped on the procedure when it was first announced in 2008 and labelled it the creation of a three-parent baby - the mother, the donor and the father - a charge scientists claim is inaccurate because the amount of DNA from the donor egg is insignificant.
"Scientists have developed ground-breaking new procedures which could stop these diseases being passed on," Britain's chief medical officer, Dr Sally Davies, said in a statement.
"It's only right that we look to introduce this life-saving treatment as soon as we can."
Earlier this year, the UK's fertility regulator said it found most people supported the new in vitro fertilisation methods after a public consultation that included hearings and written submissions. Critics have previously slammed the methods as unethical and say there are other ways for people with genetic problems to have healthy children, like egg donation or tests to screen out potentially problematic embryos.
In a response to the public consultation, the charity Christian Medical Fellowship said the techniques were unethical. "We do not consider that the hunt for 'therapies' that might prevent a small number of disabled children (with mitochondrial disease) being born justifies the destruction of hundreds if not thousands of embryonic human lives," the group said. It also said there were lingering concerns about the safety of the techniques.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
